Cargando…
Discovery of quinolone derivatives as antimycobacterial agents
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis), is an important public health issue. Current first-line drugs administered to TB patients have been in use for over 40 years, whereas second-line drugs display strong side effects and poor compliance. Ad...
Autores principales: | Liu, Kun-Lin, Teng, Fei, Xiong, Lu, Li, Xiao, Gao, Chao, Yu, Luo-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036655/ https://www.ncbi.nlm.nih.gov/pubmed/35479020 http://dx.doi.org/10.1039/d0ra09250a |
Ejemplares similares
-
Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria
por: Wube, Abraham A., et al.
Publicado: (2011) -
Synthesis and biological evaluation of novel quinolone derivatives dual targeting histone deacetylase and tubulin polymerization as antiproliferative agents
por: Wang, Xuan, et al.
Publicado: (2018) -
Design, synthesis and antimycobacterial activities of
1-methyl-2-alkenyl-4(1H)-quinolones
por: Wube, Abraham A., et al.
Publicado: (2011) -
Quinolone antibiotics
por: Pham, Thu D. M., et al.
Publicado: (2019) -
Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, in vitro and in silico antimycobacterial studies
por: Matsa, Ramkishore, et al.
Publicado: (2022)